Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma
Kuo‐Shyang Jeng, Chiung‐Fang Chang, I-Shyang Sheen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1417-1417
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma
Qinjuan Wu, Xin Li, Menghong Long, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
GART Functions as a Novel Methyltransferase in the RUVBL1/β‐Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer
Chao Tang, Mengying Ke, Xichao Yu, et al.
Advanced Science (2023) Vol. 10, Iss. 25
Open Access | Times Cited: 17
The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk
Chang Xu, Xudong Gao, Tianshu Ren, et al.
Pharmacological Research (2024) Vol. 203, pp. 107142-107142
Open Access | Times Cited: 7
Clonorchis sinensis infection amplifies hepatocellular carcinoma stemness, predicting unfavorable prognosis
Qiumei Lin, Zeli Tang, Yuling Qin, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 1, pp. e0011906-e0011906
Open Access | Times Cited: 6
The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma
Yan Lu, Bo Lin, Mengsen Li
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
Julia Pospieszna, Hanna Dams-Kozłowska, Wachirawit Udomsak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10910-10910
Open Access | Times Cited: 14
RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells
Fengxu Lv, Wentao Si, Xiaodan Xu, et al.
Neoplasia (2024) Vol. 48, pp. 100967-100967
Open Access | Times Cited: 5
Unravelling the Mysteries of the Sonic Hedgehog Pathway in Cancer Stem Cells: Activity, Crosstalk and Regulation
Carlo Berrino, Aadilah Omar
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5397-5419
Open Access | Times Cited: 4
FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway
Xi Han, Zefeng Liu, Mengying Cui, et al.
Aging (2024)
Open Access | Times Cited: 4
Ultrasound nanobubble-based combinational strategies of loaded miR-107-3p and CD133 Ab for anti-PD-L1 and anti-hepatocellular cancer stem cells
C Zhang, Yezi Chen, Jiaxuan Han, et al.
International Journal of Pharmaceutics (2025), pp. 125140-125140
Closed Access
Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications
Jianhui Wu, Xiaofang Zhao, Bowen Ren, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1839-1839
Open Access
Role of cancer stem cell heterogeneity in intrahepatic cholangiocarcinoma
Yiwang Zhang, Juping Xie, Xiangqi Huang, et al.
Translational Cancer Research (2025) Vol. 14, Iss. 2, pp. 1265-1281
Open Access
MRI Parameters and Clinicopathologic Features in Predicting Hepatocellular Carcinomas With Aggressive-Related Marker Expression, Defined by Epithelial Cell Adhesion Molecule and Glypican-3 Status
Y Li, Huo Lei, Lu Liu, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1691-1708
Open Access
The current status of tumor microenvironment and cancer stem cells in sorafenib resistance of hepatocellular carcinoma
Siqi Chen, Yaqing Du, Xin‐Yuan Guan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Histone lactylation facilitates MCM7 expression to maintain stemness and radio-resistance in hepatocellular carcinoma
Zijian Liu, Jiaqi Han, Shitong Su, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116887-116887
Closed Access
Identification of a Cancer Stem Cell-Related Gene Signature in Hepatocellular Carcinoma Based on Single-Cell RNA-Seq and Bulk RNA-Seq Analysis
Jing Wu, Xu Liu, Sheng Huang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2933-2933
Open Access
Influencing factors and mechanism of hepatocyte regeneration
Xiaoyi Zhang, Shenghao Li, Liyuan Hao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance
RF. Zaarour, Marcelo Lima Ribeiro, Bruno Azzarone, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials
Qichuan Deng, Yü Huang, Jing Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117343-117343
Open Access | Times Cited: 3
Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development
Dashuai Yang, Ying Hu, Junfa Yang, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 2, pp. 163-173
Closed Access | Times Cited: 2
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma
Ozlem Sherif, Said Khelwatty, Izhar Bagwan, et al.
Oncology Reports (2024) Vol. 52, Iss. 6
Open Access | Times Cited: 2
Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein
Xiaocui Li, Delong Kong, Wei Hu, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow
Fanbo Jing, Xiao Li, Hui Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115561-115561
Open Access | Times Cited: 5
Rab11-FIP4 interacts with ARF5 to promote cancer stemness in hepatocellular carcinoma
Feifeng Song, Qi Zhang, Xixuan Lu, et al.
Journal of Physiology and Biochemistry (2023) Vol. 79, Iss. 4, pp. 757-770
Closed Access | Times Cited: 4
Reappraisal of the Roles of the Sonic Hedgehog Signaling Pathway in Hepatocellular Carcinoma
Kuo‐Shyang Jeng, Chiung‐Fang Chang, Yuk‐Ming Tsang, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1739-1739
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top